Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0322 | ||||
| Gene Name | SLC37A1 | ||||
| Protein Name | Glycerol-3-phosphate permease | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | G-3-P permease; G3PP; Glucose-6-phosphate exchanger SLC37A1; SLC37A1; Solute carrier family 37 member 1 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Organophosphate:Pi Antiporter (OPA) Family | |||||
| Tissue Specificity | Expressed in numerous tissues, with highestexpression in pancreas, kidney, bone marrow, spleen, liver, smallintestine, as well as in fetal brain, liver and spleen. | ||||
| Function | This transporter may transport cytoplasmic glucose-6-phosphate into the lumen of the endoplasmic reticulum and translocate inorganic phosphate into the opposite direction. Independent of a lumenal glucose-6-phosphatase. | ||||
| Disease(s) | High blood glucose [ICD-11: 5C61.5] | ||||
| Endogenous Substrate(s) | Glycerol-3-phosphate | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Phosphate
|
Approved | Drug Info | Constipation | ME05.0 | [1] |
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Glucose-6-phosphate
|
Phase 1 | Drug Info | High blood glucose | 5C61.5 | [1] |
| References | |||||
| 1 | SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One. 2011;6(9):e23157. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.